Phase4 Partners

Phase4 Partners is a venture capital firm specializing in early-stage and growth-stage investments in the healthcare sector. Founded in 1999 and led by Managing Partner Denise Pollard-Knight, the firm focuses on companies transforming healthcare, including biotechnology, medical devices, digital health, and diagnostics. The team brings together a unique blend of industry expertise, operational experience, and a passion for innovation.

The firm's investment strategy emphasizes building enduring partnerships with founders who share a vision of improving global health. Beyond capital, Phase4 Partners provides strategic guidance, operational support, and access to a global network of industry leaders. They have invested over $400 million in 24 companies in both Europe and the US, including notable successes such as Pharmion, Arakis, Proteolix, Albireo, and OncoMed.

Phase4 Partners is a member of the British Private Equity and Venture Capital Association (BVCA) and the European Private Equity and Venture Capital Association (EVCA).